ZD6474, a co-inhibiter of VEGFR/EGFR and mTOR kinases, is also illustrated substantially higher anti-proliferative activity than either VEGFR inhibitor or EGFR inhibitor alone applied in cancers [18]. This evidence concerns the gene EGFR and cancer.